Connecting you to content on EBSCOhost

Works by Guijarro, Francisca

Results: 3

Diverse real-life outcomes after intensive risk-adapted therapy for 1034 AML patients from the CETLAM Group.
Published in:
Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-024-01205-5
By:
- Oñate, Guadalupe;
- Garrido, Ana;
- Arnan, Montserrat;
- Pomares, Helena;
- Alonso, Ester;
- Tormo, Mar;
- Diaz-Beya, Marina;
- Vives, Susana;
- Zamora, Lurdes;
- Sampol, Antonia;
- Coll, Rosa;
- Salamero, Olga;
- Cervera, Marta;
- Garcia, Antoni;
- Vall-Llovera, Ferran;
- Garcia-Avila, Sara;
- Bargay, Joan;
- Ortin, Xavier;
- Iranzo, Eva;
- Guijarro, Francisca
Publication type:
Article
Multinucleated giant myeloma cells after failure of daratumumab therapy.
Published in:
2018
By:
- Guijarro, Francisca;
- Rozman, María;
- Matutes, Estella
Publication type:
Case Study
24‐h continuous infusion of platelets for patients with platelet transfusion refractoriness.
Published in:
2018
By:
- Cid, Joan;
- Guijarro, Francisca;
- Carbassé, Gloria;
- Lozano, Miguel
Publication type:
Letter to the Editor